Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Survodutide

A Study in People With Obesity to Test the Effects of BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver

Boehringer Ingelheim · Phase 1 · Active, not recruiting · Enrollment 29

NCT05202353

EudraCT 2021-000363-76

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Group 1: BI 456906n/rn/rn/rn/r
Group 2: Semaglutiden/rn/rn/rn/r
Group 3: BI 456906n/rn/rn/rn/r
Group 4: Semaglutiden/rn/rn/rn/r

Not shown

  • Group 1: BI 456906: endpoint not reported
  • Group 2: Semaglutide: endpoint not reported
  • Group 3: BI 456906: endpoint not reported
  • Group 4: Semaglutide: endpoint not reported